|
333-211719
|
|
81-2587835
|
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
|
[ ]
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
§
|
Unaudited Condensed Pro Forma Consolidated Balance Sheet as of March 31, 2017; and Unaudited Condensed Pro Forma Statements of Consolidated Income for the six months ended March 31, 2017 and for each of the three fiscal years ended September 30, 2016, 2015 and 2014
|
(d)
|
Exhibits
|
|
Exhibit Number
|
Description of Exhibit
|
|
|
99.1
|
News Release dated May 12, 2017.
|
|
99.2
|
Unaudited Condensed Pro Forma Consolidated Balance Sheet of Ashland Global Holdings Inc. and Consolidated Subsidiaries as of March 31, 2017; and Unaudited Condensed Pro Forma Statements of Consolidated Income for the six months ended March 31, 2017 and for each of the three fiscal years ended September 30, 2016, 2015 and 2014.
|
|
ASHLAND GLOBAL HOLDINGS INC.
|
|
(Registrant)
|
|
|
|
|
May 12, 2017
|
/s/ Peter J. Ganz |
|
Peter J. Ganz
|
|
Senior Vice President, General Counsel and
Secretary
|
Exhibit Number
|
Description of Exhibit
|
99.1
|
News release dated May 12, 2017.
|
99.2
|
Unaudited Condensed Pro Forma Consolidated Balance Sheet of Ashland Global Holdings Inc. and Consolidated Subsidiaries as of March 31, 2017; and Unaudited Condensed Pro Forma Statements of Consolidated Income for the six months ended March 31, 2017 and for each of the three fiscal years ended September 30, 2016, 2015 and 2014.
|
Ashland Global Holdings Inc. and Consolidated Subsidiaries
|
||||||||||||||||
Unaudited Condensed Pro Forma Consolidated Balance Sheet
|
||||||||||||||||
March 31, 2017
|
||||||||||||||||
(a)
|
(d)
|
|||||||||||||||
(In millions)
|
Historical
|
Valvoline
|
Adjustments
|
Pro Forma
|
||||||||||||
ASSETS
|
||||||||||||||||
Current assets
|
||||||||||||||||
Cash and cash equivalents
|
$
|
605
|
$
|
(135
|
)
|
$
|
-
|
$
|
470
|
|||||||
Accounts receivable | 972 | (402 | ) | - | 570 | |||||||||||
Inventories
|
687
|
(148
|
)
|
-
|
539
|
|||||||||||
Other assets
|
113
|
(25
|
)
|
11
|
99
|
|||||||||||
Total current assets
|
2,377
|
(710
|
)
|
11
|
1,678
|
|||||||||||
Noncurrent assets
|
||||||||||||||||
Property, plant and equipment
|
||||||||||||||||
Cost
|
4,364
|
(765
|
)
|
-
|
3,599
|
|||||||||||
Accumulated depreciation
|
2,159
|
(416
|
)
|
-
|
1,743
|
|||||||||||
Net property, plant and equipment
|
2,205
|
(349
|
)
|
-
|
1,856
|
|||||||||||
Goodwill
|
2,413
|
(312
|
)
|
-
|
2,101
|
|||||||||||
Intangibles
|
1,017
|
(6
|
)
|
-
|
1,011
|
|||||||||||
Restricted investments
|
298
|
-
|
-
|
298
|
||||||||||||
Asbestos insurance receivable
|
193
|
-
|
-
|
193
|
||||||||||||
Equity and other unconsolidated investments
|
61
|
(30
|
)
|
-
|
31
|
|||||||||||
Deferred income taxes
|
199
|
-
|
(163
|
)
|
36
|
|||||||||||
Other assets
|
423
|
(85
|
)
|
77
|
415
|
|||||||||||
Total noncurrent assets
|
6,809
|
(782
|
)
|
(86
|
)
|
5,941
|
||||||||||
Total assets
|
$
|
9,186
|
$
|
(1,492
|
)
|
$
|
(75
|
)
|
$
|
7,619
|
||||||
LIABILITIES AND EQUITY
|
||||||||||||||||
Current liabilities
|
||||||||||||||||
Short-term debt
|
$
|
95
|
$
|
(75
|
)
|
$
|
-
|
$
|
20
|
|||||||
Current portion of long-term debt
|
16
|
(16
|
)
|
-
|
-
|
|||||||||||
Trade and other payables
|
520
|
(173
|
)
|
-
|
347
|
|||||||||||
Accrued expenses and other liabilities
|
406
|
(181
|
)
|
11
|
236
|
|||||||||||
Total current liabilities
|
1,037
|
(445
|
)
|
11
|
603
|
|||||||||||
Noncurrent liabilities
|
||||||||||||||||
Long-term debt
|
2,812
|
(656
|
)
|
-
|
2,156
|
|||||||||||
Employee benefit obligations
|
1,017
|
(833
|
)
|
-
|
184
|
|||||||||||
Asbestos litigation reserve
|
663
|
-
|
-
|
663
|
||||||||||||
Deferred income taxes
|
69
|
389
|
(163
|
)
|
295
|
|||||||||||
Other liabilities
|
445
|
(162
|
)
|
77
|
360
|
|||||||||||
Total noncurrent liabilities
|
5,006
|
(1,262
|
)
|
(86
|
)
|
3,658
|
||||||||||
Equity
|
||||||||||||||||
Total Ashland stockholders' equity
|
3,300
|
58
|
-
|
3,358
|
||||||||||||
Noncontrolling interest
|
(157
|
)
|
157
|
-
|
-
|
|||||||||||
Total equity
|
3,143
|
215
|
-
|
3,358
|
||||||||||||
Total liabilities and equity
|
$
|
9,186
|
$
|
(1,492
|
)
|
$
|
(75
|
)
|
$
|
7,619
|
||||||
See Notes to Unaudited Condensed Pro Forma Consolidated Financial Statements.
|
Unaudited Condensed Pro Forma Statement of Consolidated Income
|
|||||||||||||
Year ended September 30, 2016
|
|||||||||||||
(b)
|
|||||||||||||
(In millions except per share data)
|
Historical
|
Valvoline
|
Pro Forma
|
||||||||||
Sales
|
$
|
4,948
|
$
|
(1,929
|
)
|
$
|
3,019
|
||||||
Cost of sales
|
3,321
|
(1,168
|
)
|
2,153
|
|||||||||
Gross profit
|
1,627
|
(761
|
)
|
866
|
|||||||||
Selling, general and administrative expense
|
1,228
|
(314
|
)
|
914
|
|||||||||
Research and development expense
|
100
|
(13
|
)
|
87
|
|||||||||
Equity and other income
|
28
|
(20
|
)
|
8
|
|||||||||
Operating income (loss)
|
327
|
(454
|
)
|
(127
|
)
|
||||||||
Net interest and other financing expense
|
182
|
(9
|
)
|
173
|
|||||||||
Net loss on divestitures
|
(9
|
)
|
1
|
(8
|
)
|
||||||||
Income (loss) from continuing operations before income taxes
|
136
|
(444
|
)
|
(308
|
)
|
||||||||
Income tax expense (benefit)
|
133
|
(158
|
)
|
(25
|
)
|
||||||||
Income (loss) from continuing operations
|
$
|
3
|
$
|
(286
|
)
|
$
|
(283
|
)
|
|||||
Earnings per share from continuing operations attributable to Ashland
|
|||||||||||||
Basic
|
$
|
0.03
|
|
|
|
$
|
(4.51
|
)
|
|||||
Diluted
|
0.03
|
|
|
(4.51
|
)
|
||||||||
Average common shares outstanding (in millions)
|
|||||||||||||
Basic
|
63
|
|
63
|
||||||||||
Diluted
|
64
|
|
|
63
|
(c)
|
||||||||
See Notes to Unaudited Condensed Pro Forma Consolidated Financial Statements.
|
Unaudited Condensed Pro Forma Statement of Consolidated Income
|
|||||||||||||
Year ended September 30, 2015
|
|||||||||||||
(b)
|
|||||||||||||
(In millions except per share data)
|
Historical
|
Valvoline
|
Pro Forma
|
||||||||||
Sales
|
$
|
5,387
|
$
|
(1,967
|
)
|
$
|
3,420
|
||||||
Cost of sales
|
3,814
|
(1,282
|
)
|
2,532
|
|||||||||
Gross profit
|
1,573
|
(685
|
)
|
888
|
|||||||||
Selling, general and administrative expense
|
1,028
|
(336
|
)
|
692
|
|||||||||
Research and development expense
|
110
|
(11
|
)
|
99
|
|||||||||
Equity and other income
|
23
|
(8
|
)
|
15
|
|||||||||
Operating income
|
458
|
(346
|
)
|
112
|
|||||||||
Net interest and other financing expense
|
174
|
-
|
174
|
||||||||||
Net loss on divestitures
|
(115
|
)
|
26
|
(89
|
)
|
||||||||
Income (loss) from continuing operations before income taxes
|
169
|
(320
|
)
|
(151
|
)
|
||||||||
Income tax benefit
|
(22
|
)
|
(117
|
)
|
(139
|
)
|
|||||||
Income (loss) from continuing operations
|
$
|
191
|
$
|
(203
|
)
|
$
|
(12
|
)
|
|||||
Earnings per share from continuing operations
|
|||||||||||||
Basic
|
$
|
2.81
|
|
|
|
$
|
(0.18
|
)
|
|||||
Diluted
|
2.78
|
|
|
(0.18
|
)
|
||||||||
Average common shares outstanding (in millions)
|
|||||||||||||
Basic
|
68
|
|
68
|
||||||||||
Diluted
|
69
|
|
|
68
|
(c)
|
||||||||
See Notes to Unaudited Condensed Pro Forma Consolidated Financial Statements.
|
Unaudited Condensed Pro Forma Statement of Consolidated Income
|
|||||||||||||
Year ended September 30, 2014
|
|||||||||||||
(b)
|
|||||||||||||
(In millions except per share data)
|
Historical
|
Valvoline
|
Pro Forma
|
||||||||||
Sales
|
$
|
6,121
|
$
|
(2,041
|
)
|
$
|
4,080
|
||||||
Cost of sales
|
4,605
|
(1,409
|
)
|
3,196
|
|||||||||
Gross profit
|
1,516
|
(632
|
)
|
884
|
|||||||||
Selling, general and administrative expense
|
1,358
|
(356
|
)
|
1,002
|
|||||||||
Research and development expense
|
114
|
(11
|
)
|
103
|
|||||||||
Equity and other income (loss)
|
2
|
(30
|
)
|
(28
|
)
|
||||||||
Operating income (loss)
|
46
|
(295
|
)
|
(249
|
)
|
||||||||
Net interest and other financing expense
|
166
|
-
|
166
|
||||||||||
Net gain on divestitures
|
4
|
-
|
4
|
||||||||||
Loss from continuing operations before income taxes
|
(116
|
)
|
(295
|
)
|
(411
|
)
|
|||||||
Income tax benefit
|
(188
|
)
|
(102
|
)
|
(290
|
)
|
|||||||
Income (loss) from continuing operations
|
$
|
72
|
$
|
(193
|
)
|
$
|
(121
|
)
|
|||||
Earnings per share from continuing operations
|
|||||||||||||
Basic
|
$
|
0.94
|
|
|
|
$
|
(1.57
|
)
|
|||||
Diluted
|
0.93
|
|
|
(1.57
|
)
|
||||||||
Average common shares outstanding (in millions)
|
|||||||||||||
Basic
|
77
|
|
77
|
||||||||||
Diluted
|
78
|
|
|
77
|
(c)
|
||||||||
See Notes to Unaudited Condensed Pro Forma Consolidated Financial Statements.
|